Softigel’s seven cutting-edge facilities house a fully integrated product development services (PDS) unit, which covers a wide range of product lifecycle phases from early development to commercialisation in the same plant, using equipment replication from lab scale, through small-scale good manufacturing practice (GMP) batches, until full-scale commercial GMP.
The development group provides clients with access to formulation development, process development, clinical trial materials (CTM) manufacturing, and scale-up services for a range of softgel types and other drug delivery forms, from Phase I scale, scale-up and registration, through to large scale commercial production.
A key factor in our market success is having a research and development (R&D) team working continuously in the development of formulas and pharmaceutical technologies. By combining new synthetic and natural substances with high-tech research equipment and new drug delivery systems, Softigel offers differentiated products.